FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 296

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
BNTC Nasdaq Benitec Biopharma Inc. 2830
CADL Nasdaq Candel Therapeutics, Inc. 2830
CANF NYSE American Can-Fite BioPharma Ltd. 2830
CASI Nasdaq CASI Pharmaceuticals, Inc. 2830
CDMO Nasdaq Avid Bioservices, Inc. 2830
CDT Nasdaq Conduit Pharmaceuticals Inc. 2830
CDTX Nasdaq Cidara Therapeutics, Inc. 2830
CDXS Nasdaq Codexis, Inc. 2830
CELZ Nasdaq Creative Medical Technology Holdings, In 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEN Nasdaq Compugen Ltd. 2830
CLYM Nasdaq Climb Bio, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
CNTA Nasdaq Centessa Pharmaceuticals plc 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
COEP Nasdaq Coeptis Therapeutics Holdings, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CRBP Nasdaq Corbus Pharmaceuticals Holdings, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CTXR Nasdaq Citius Pharmaceuticals, Inc. 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DERM Nasdaq Journey Medical Corporation 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRTS Nasdaq Alpha Tau Medical Ltd. 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
ELVN Nasdaq Enliven Therapeutics, Inc. 2830
ENLV Nasdaq Enlivex Therapeutics Ltd. 2830
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2830
ETNB Nasdaq 89bio, Inc. 2830
EVAX Nasdaq Evaxion Biotech A/S 2830
EVO Nasdaq Evotec SE 2830
EVOK Nasdaq Evoke Pharma, Inc. 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
EYPT Nasdaq EyePoint Pharmaceuticals, Inc. 2830
FENC Nasdaq Fennec Pharmaceuticals Inc. 2830
FHTX Nasdaq Foghorn Therapeutics Inc. 2830
FOLD Nasdaq Amicus Therapeutics, Inc. 2830
FTRE Nasdaq Fortrea Holdings Inc. 2830
Results 50 through 100 of 296